O'Brien Terrence P, Awwad Shady T
Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-9121, USA.
Curr Opin Ophthalmol. 2002 Aug;13(4):264-70. doi: 10.1097/00055735-200208000-00015.
Phakic intraocular lens implantation (IOLs) and clear lens extraction for high to extreme myopia have grown in popularity recently as a consequence of potentially unsatisfactory results with corneal refractive surgery in higher ranges of refractive errors. The refractive outcome of these alternative modalities has been encouraging to date, yet the potential for significant complications exists. Current evidence shows that the risk of retinal detachment after clear lens extraction for myopes is high. Trials with angle-supported phakic IOLs revealed unacceptable rates of pupillary ovalization, IOL rotation, and endothelial cell loss. Iris-fixated and posterior chamber phakic IOLs have proven sufficient safety, but long-term follow-ups of current cohorts are still to be awaited. The implantation of either of the latter two phakic IOLs followed by laser in situ keratomileusis or photorefractive keratectomy (bioptics) provides another option in refractive surgery for high ametropia.
由于在较高屈光不正范围内角膜屈光手术的结果可能不尽人意,有晶体眼人工晶状体植入术(IOL)和透明晶状体摘除术治疗高度至超高度近视近来越来越受欢迎。迄今为止,这些替代方法的屈光效果令人鼓舞,但仍存在发生严重并发症的可能性。目前的证据表明,近视患者行透明晶状体摘除术后视网膜脱离的风险很高。有晶状体眼角度支撑型人工晶状体的试验显示,瞳孔椭圆化、人工晶状体旋转和内皮细胞丢失的发生率令人难以接受。虹膜固定型和后房型有晶状体眼人工晶状体已被证明具有足够的安全性,但目前队列的长期随访仍有待进行。植入后两种有晶状体眼人工晶状体中的任何一种,再行准分子原位角膜磨镶术或准分子激光角膜切削术(联合手术),为高度屈光不正的屈光手术提供了另一种选择。